Naoki Hiramatsu - Concepedia

Author

Naoki Hiramatsu

Also Known As

Katsuo Hayashi, Liver, M Kurosaki, N HIRAMATSU, N Hiramatsu, N. Hiramatsu, Naoki HIRAMATSU, Naoki Hiramatsu, Ryoko Yamada

242

Publications

6.8K

Citations

H-Index

150

Concepts

All Affiliations

The University of Osaka Ikeda Municipal Hospital Osaka National Hospital Kansai Rosai Hospital Osaka Police Hospital

About

Naoki Hiramatsu is an author at The University of Osaka specializing in medicine, hepatitis, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	62	3.5K
2	Social Sciences	9	9	286
3	Health Sciences	7	7	367
4	Engineering	2	2	72
5	Allergy	1	1	16

Naoki Hiramatsu

126

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice Satoshi Tanaka, Hayato Hikita, Tomohide Tatsumi, Hepatology	2016	361
Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C Naoki Hiramatsu, Norio Hayashi, Kazuhiro Katayama, Hepatology ImmunologyPathologyCell DeathFas AntigenLiver Biopsy	1994	358
Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis Kiyoshi Ashida, Yuichi Sakurai, Tetsuharu Hori, Alimentary Pharmacology & Therapeutics	2015	291
Negative Regulation of NK Cell Activities by Inhibitory Receptor CD94/NKG2A Leads to Altered NK Cell-Induced Modulation of Dendritic Cell Functions in Chronic Hepatitis C Virus Infection Masahisa Jinushi, Tetsuo Takehara, Tomohide Tatsumi, The Journal of Immunology T-regulatory CellImmunologyNk CellsImmunologic MechanismNk Receptor	2004	223
Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas Masahisa Jinushi, Tetsuo Takehara, Tomohide Tatsumi, Journal of Hepatology Cancer ImmunosurveillanceAutoimmune DiseaseSoluble FormImmunologyHepatitis	2005	217
Reduced Numbers and Impaired Ability of Myeloid and Plasmacytoid Dendritic Cells to Polarize T Helper Cells in Chronic Hepatitis C Virus Infection Tatsuya Kanto, Michiyo Inoue, Hideki Miyatake, The Journal of Infectious Diseases Hepatitis C VirusImmunologyImmune RegulationPathologyCd4 T Cell Responses	2004	214
Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis Kiyoshi Ashida, Yuichi Sakurai, Akira Nishimura, Alimentary Pharmacology & Therapeutics	2015	184
Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial Akinori Kasahara, Norio Hayashi, Naoki Hiramatsu, Hepatology Prolonged Interferon TreatmentHepatologyHepatitis CViral HepatitisImmunology	1995	161
Fas antigen expression in liver tissues of patients with chronic hepatitis B Kiyoshi Mochizuki, Norio Hayashi, Naoki Hiramatsu, Journal of Hepatology Liver TissuesAutoimmune DiseaseHepatologyViral HepatitisLiver Physiology	1996	144
Atypical, bidirectional regulation of cadmium-induced apoptosis via distinct signaling of unfolded protein response Makiko Yokouchi, Naoki Hiramatsu, Kunihiro Hayakawa, Cell Death and Differentiation Reductive StressSignal TransductionBioactive MetalMetalloproteinApoptosis	2007	139

Page 1